Clinical Trial Results:
An Open-label, Multicenter, Phase 2 Study of Single-agent
CNTO 888 (an anti-CCL2 Monoclonal Antibody) for the
Treatment of Subjects with Metastatic Castrate-Resistant Prostate
Cancer
Summary
|
|
EudraCT number |
2009-011251-48 |
Trial protocol |
GB BE |
Global completion date |
06 Jul 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
01 Dec 2016
|
First version publication date |
01 Dec 2016
|
Other versions |
|
Summary report(s) |
CNTO888PCR2001_2009-011251-48_ct.gov results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.